Zodl has launched a waitlist for its new macOS Vault app designed for long-term self-custody of shielded Zcash (ZEC). Beta access will be granted in batches of 100 users, though no public launch date or tester selection criteria have been disclosed. The Vault app complements Zodl's existing mobile wallet, which supports hardware signing and private payments with shielded ZEC. This move aims to enhance privacy and security for ZEC holders, with over 4,100 beta signups reported so far. Future updates may expand features and platform support.
Zodl Vault's upcoming beta access for Zcash holders provides context for cryptocurrency market activity. For readers following major cryptocurrencies on Pluang, here is the market snapshot as of Oct 21, 2026 01:21 WIB: out of 50 major cryptocurrencies, 44 rose and 5 fell today. Notable movers include EOS (EOS.IO) at Rp12.649 with an 8.13% increase and a typical hold time of 87 days, AXS (Axie Infinity) at Rp18.981 with a 5.51% rise but 100% sell order activity, and COTI at Rp202 with a 5.44% gain and a typical hold time of 121 days.
Moody's is expected to report Q3 2026 earnings of around $4.25 per share on revenue near $2.08 billion, driven by steady demand for credit ratings and growth in Moody's Analytics, especially from recurring subscriptions and AI tools. While Moody's In...
Raymond James increased its price target for Rapport Therapeutics to $86 following positive Phase 2 trial results of RAP-219, a drug treating acute bipolar mania. The trial showed statistically significant improvement in patients and a favorable safe...
Heartland Express reported a third-quarter 2026 revenue decline of 8.7% to $179.5 million, missing analyst estimates. Despite lower revenue, the company returned to profitability with a net income of $1.0 million, compared to a loss last year. The op...
Catholic Medical Mission Board (CMMB) held a ribbon-cutting ceremony for its new Distribution Center at the Brethren Service Center in New Windsor, Maryland. This move enhances CMMB's Access to Medicines Program by expanding operational capacity and ...
Piper Sandler upgraded Myriad Genetics from Underweight to Neutral and set a $5.00 price target after the company agreed to sell its prenatal health testing business to Labcorp for $210 million in cash. This sale includes several prenatal tests and i...
